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“Cancer, unlike politics and religion is not a topic 
of controversy.  No one is for it.”
-S. Mooney, 1989, A Snowflake in My Hand
Comparative Oncology (Re-)Defined
The shortest route may not be the best
Limitations of rodent models
 Incompetent immune system
 Lack heterogeneity
 Rapid tumor progression
 Biosampling limitations
A different kind of lab
UMC VMTH Oncology

Advantages of companion animal models
 Standard of care may not exist
 Anatomical size and structural 
similarity allows refinement of 
surgical and other techniques
Ability to assess outcome when 
treating minimal residual 
disease
Cancer in Domestic Animals
• Cancer is the leading cause of death in dogs
• Necropsy (autopsy) study of 2000 dogs*:
• 23% of all dogs died of cancer
• 45% of dogs >10 years died of cancer
• Improved methods of diagnosis
• Increased demand for care
*Bronson RT, AJVR 1982;43:2057-2059
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Why are animal cancer models useful?
 Shared environment
Why are animal cancer models useful?
 Shorter life span
Why are animal cancer models useful?
 Controllable factors
• lifestyle choices
• diet
• hormonal status
• placebo effect
Why are animal cancer models useful?
 Outbred vs. inbred 
populations
Why are animal cancer models useful?
 Genetics and pedigree 
may be known
Why are animal cancer models useful?
• Spontaneously-arising tumors
• Variables in natural state of disease
Why are animal cancer models useful?
Why are animal cancer models useful?
• Similar diagnostic tools
Why are animal cancer models useful?
Why are animal cancer models useful?
• Approvals are simplified
Why are animal cancer models useful?
• Necropsy more likely
Clinical Research Using Animal 
Tumor Models: A win-win
Funding Opportunities

Translational and Comparative Oncology-
an Updated NCI Perspective
Comparative Oncology Trials Consortium
translational research/clinical trial consortium under 
the NCI umbrella
Canine Comparative Oncology and 
Genomics Consortium
biospecimen repository development



Unique Tools
Veterinary Medical Database
 Most comprehensive veterinary database 
 Began at Michigan State University in 1964
 Today 27 North American veterinary teaching hospitals are 
included
 PhD project at MU centered on “cleaning up” this database; 
now in searchable format without duplications

Partnerships with Industry
The Shared Goal: The Search for the Perfect Marker
Screening Test for Lymphoma
 PetScreen Ltd, Biocity, Nottingham UK
 Commercially available proteomic identification and 
profiling test for canine lymphoma
 Chance conversation at BSAVA meeting in 2007
Partnerships with Industry
 PetScreen North American lab now sited in Columbia, MO 
at the Life Sciences Business Incubator
 Synergy with Proteomics Core in MU Life Sciences Center
 Teaching, research, and service missions
Developmental Therapeutics
Clinical Trials –Successes in Vet Oncology
 Canine Oral Melanoma Vaccine by Merial utilizing human 
tyrosinase
 USDA Approval in 2007; partnership between AMCNY and MMSKCC
 Samarium-153-EDTMP for Canine Osteosarcoma
 radiopharmaceutical that targets bone lesions
 developed at MU, tested in dogs, now marketed as Quadramet for people
 Canine Mast Cell Tumors: can target c-kit with receptor tyrosine 
kinase inhibitors 
 Palladia: Pfizer product approved by FDA in 2009
 Masitinib: AB Science product approved in Europe
Clinical Trials –Ongoing
 Hormone-refractory prostate CA
 Intratumoral gold nanoparticles delivery by EUS;  minimally invasive surgery
 Muscle-invasive bladder CA
 Chemotherapy , COX inhibitor, and Tavocept
 EGCG infusion
 Feline Oral Squamous Cell Carcinoma
 Retinoids and Interferon
 Primary and metastatic lung cancer
 Inhalant chemotherapy  -J Aerosol Med and Pulmonary Drug Delivery, 
2008;21(3):255.
 Evaluation of exhaled breath condensate
 Lymphoma
 Molecular imaging of bcl-2 J Nuclear Medicine Vol. 49 No. 3: 430
Other Avenues of Investigation
 Additional epidemiologic investigations
 Mesothelioma – 240 cases in dogs; sentinels?
 Breast cancer – methylation changes; effect of diet
 Identification of genetic and epigenetic modifications
 Familial adenomatous polyposis in dogs? Association with APC or MUTYH?
ATF-2 in Standard Poodles
 Lymphoma
 In vivo modeling
 Photoacoustic identification of melanoma micrometastases J. Biomech. 
Eng. July 2009; 31 (7); 074519
 Effect of timing of post-surgical radiation on wound healing

Parting Thoughts/Questions?
